Trademark Overview
On Monday, October 20, 2025, a trademark application was filed for RILGOVIC with the United States Patent and Trademark Office. The USPTO has given the RILGOVIC trademark a serial number of 99452029. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, October 20, 2025. This trademark is owned by Sanofi. The RILGOVIC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare immune-system related, rare inflammatory, and rare neurological diseases and disorders